● CATEGORY · WEIGHT LOSS156 PROFILES · INDEXED
The weight loss.
156 peptide profiles with mechanisms, dosing protocols, research summaries, and safety data.
GLP-1 agonists, metabolic regulators, and fat-loss compounds.
SHOWING · 21–24 OF 24 · WEIGHT LOSS · PAGE 2 OF 2
24 profiles
021
CagriSema
Cagrilintide-Semaglutide · CagriSema 2.4/2.4 · amylin-GLP-1 combination
Weight Loss
CagriSema is a fixed-dose co-formulation combining cagrilintide (a long-acting amylin analogue) and semaglutide (a GLP-1 receptor agonist), both at 2.
Research Only
→
022
Orforglipron
LY3502970
Weight Loss
Orforglipron (LY3502970) is an oral, once-daily, non-peptide small-molecule GLP-1 receptor agonist developed by Eli Lilly (originally discovered by Chugai Pharmaceutical).
Research Only
→
023
Survodutide
BI 456906 · BI-456906
Weight Loss
Survodutide (BI 456906) is a dual glucagon receptor (GCGR) and GLP-1 receptor (GLP-1R) agonist developed by Boehringer Ingelheim and Zealand Pharma.
Research Only
→
024
VK2735
VK-2735
Weight Loss
VK2735 is a novel synthetic dual agonist of the GLP-1 and GIP receptors developed by Viking Therapeutics for treatment of obesity and metabolic disorders.
Research Only
→